产品说明
制备说明
Tetrahydrofurane / N-Methylimidazole / Pyridine 8/1/1 (v/v/v)
其他说明
Cap B solution, containing tetrahydrofuran (THF), pyridine and N-methylimidazole (NMI), is mixed in situ with Cap A solution during the capping (acetylation) reaction. Pyridine is applied as a mild base while NMI provides a powerful acylation catalyst.
基本信息
| NACRES | NA.21 |
产品性质
| 产品线 | Proligo Reagents |
| 质量水平 | 200 |
安全信息
| 象形图 |     |
| 警示用语： | Danger |
| 危险声明 | H225 - H302 + H312 - H314 - H335 - H336 - H351 |
| 预防措施声明 | P210 - P280 - P301 + P312 - P303 + P361 + P353 - P304 + P340 + P310 - P305 + P351 + P338 |
| 危险分类 | Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Carc. 2 - Eye Dam. 1 - Flam. Liq. 2 - Skin Corr. 1B |
| 补充剂危害 | EUH019 |
| 储存分类代码 | 3 - Flammable liquids |
| WGK | WGK 2 |
| 闪点(F) | 6.1 °F |
| 闪点(C) | -14.4 ℃ |
Sigma-Aldrich
m.cnreagent.com
